NPPB and coronary artery disorder: Today, monitoring blood levels of BNP together with cardiac troponins T/I became standard clinical biomarkers for the diagnosis, prognosis and evaluation of cardiovascular risk of patients with cardiac diseases, including ischemic heart disease and heart failure [93,94,95].